Similar Posts
Psychedelic Business Spotlight – April 8
This week in psychedelic business news: Field Trip Health secures a patent; Core One Labs seeks more retail investors; a new CEO takes over GABA Therapeutics.
Ketamine Rapidly Reduces Depression, According to ‘Most Comprehensive Review’ of Evidence — But Patient Experiences Suggest More Applications
Psychedelic Spotlight speaks to a Field Trip Health patient and a psychotherapist, whose experiences suggest ketamine can also treat anxiety among other mental health issues.
5 Powerful Life-Changing Realizations People Had On Psychedelics
We explore some of the life-altering realizations that can come from immersive psychedelic journeys – along with some stories!
Who Is Stanislav Grof? Meet the Psychedelic Pioneer and Father of Holotropic Breathwork
Stanislav Grof is one of the earliest pioneers in psychedelics and holotropic breathwork.
Psychedelic Business Spotlight: October 8, 2021
This week in psychedelic business news: Enveric Biosciences uses AI to identify viable psychedelic drug candidates; Novamind launches end-of-life palliative care program; and PharmaTher tests ketamine to treat Parkinson’s Disease.
Biotech Firm PsyBio Therapeutics Is Producing Psilocybin From Bacteria
PsyBio Therapeutics is harvesting the psychedelic compound psilocybin from a strain of bacteria instead of mushrooms.